Cleared Traditional

K830292 - BIOELECTRICAL IMPEDANCE ANALYZER #101

K830292 is the FDA 510(k) clearance for BIOELECTRICAL IMPEDANCE ANALYZER #101 by Rjl Systems, Inc.. It is a Class 2 Cardiovascular device (product code DSB) cleared through the Traditional 510(k) pathway after a 197-day FDA review.

K830292 · Rjl Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1983
Decision
197d
Days
Class 2
Risk

K830292 is an FDA 510(k) clearance for the BIOELECTRICAL IMPEDANCE ANALYZER #101. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by Rjl Systems, Inc. (Walker, US). The FDA issued a Cleared decision on August 12, 1983 after a review of 197 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Rjl Systems, Inc. devices

Submission Details

510(k) Number K830292 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 27, 1983
Decision Date August 12, 1983
Days to Decision 197 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 125d · This submission: 197d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.